Product Policies, Access and Manufacturing Support Unit
Unit Head Office
Technical Teams
Dr Jicui Dong - Unit Head
Essential Medicines and Substances Access and Use
Medical Devices and Assistive Technology
Product Development and Manufacturing Support
Feature stories
All →News
All →Assistive technology publications
All →Assistive technology progress assessment questionnaire: tracking progress on access to assistive technology
In May 2018, the World Health Assembly (WHA) adopted resolution WHA71.8 on improving access to assistive technology. The resolution urges Member States...
Improving access to assistive technology in United Republic of Tanzania (2022-2023): project report
The report summarizes a collaboration between the Ministry of Health of the United Republic of Tanzania, HelpAge Tanzania and the World Health Organization...
Enabling rapid access to essential assistive technology in Ukraine (2022-2023): project report
This report summarizes a collaboration between the Ministry of Health of Ukraine and the World Health Organization (WHO) in 2022 and 2023. The goal was...
Accelerating access to assistive technology: Eastern Mediterranean Regional workshop report, Cairo, Egypt,...
From 3 to 5 December 2024, the World Health Organization (WHO), in collaboration with the United Nations Children’s Fund (UNICEF), convened a regional...
Essential medicines publications
All →The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification...
The AWaRe classification is intended as a tool for monitoring antibiotic use, defining targets and monitoring the impact of stewardship policies and interventions...
The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines for Children,...
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...
The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...
The selection and use of essential medicines, 2025: report of the 25th WHO Expert Committee on Selection...
This executive summary reports the recommendations made by the Expert Committee on Selection and Use of Essential Medicines for the 2025 update of the...
In vitro diagnostics publications
All →The selection and use of essential in vitro diagnostics: report of the fourth meeting of the WHO Strategic...
The Technical report of the fourth meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2022 (including the fourth WHO model...
Target product profile for readers of rapid diagnostic tests
Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the management and diagnosis of infectious diseases, including...
Selection of essential in vitro diagnostics at country level: using the WHO Model List of Essential In...
This document intends to provide guidance to countries on methods for developing and updating national lists of essential in vitro diagnostics (NEDL)....
Guidance for post-market surveillance and market surveillance of medical devices, including in vitro...
Post-market surveillance is a set of activities conducted by manufacturers, to collect and evaluate experience gained from medical devices that have...
Medical devices publications
All →Development of medical device policies, 2nd ed.
A first edition of the Development of Medical Devices Policies was published in 2011. This second edition was prepared to reflect the transition from the...
Availability, price and affordability of health technologies for the management of diabetes
The WHO list of priority medical devices for management of cardiovascular diseases and diabetes, https://iris.who.int/handle/10665/341967, describes those...
Health-care technology has played a fundamental role in medicine for centuries, evolving with scientific advances to improve patient diagnosis, treatment...
HTA is a multidisciplinary process used to evaluate the clinical, economic, ethical implications and social impact of new health technologies. This...
Videos